Accurate discrimination of pancreatic ductal adenocarcinoma and chronic pancreatitis using multimarker expression data and samples obtained by minimally invasive fine needle aspiration.
about
Mesothelin is a specific biomarker of invasive cancer in the Barrett-associated adenocarcinoma progression model: translational implications for diagnosis and therapy.C4.4A as a candidate marker in the diagnosis of colorectal cancerHead mass in chronic pancreatitis: Inflammatory or malignantMolecular imaging of pancreatic cancer in an animal model using targeted multifunctional nanoparticles.Mucin 1 (MUC1) is a novel partner for MAL2 in breast carcinoma cells.Analysis of microRNAs in pancreatic fine-needle aspirates can classify benign and malignant tissues.MAL2 and tumor protein D52 (TPD52) are frequently overexpressed in ovarian carcinoma, but differentially associated with histological subtype and patient outcome.Tumor Penetrating Theranostic Nanoparticles for Enhancement of Targeted and Image-guided Drug Delivery into Peritoneal Tumors following Intraperitoneal Delivery.Current and future intraoperative imaging strategies to increase radical resection rates in pancreatic cancer surgery.Role of endoscopic ultrasound in the molecular diagnosis of pancreatic cancer.Reliable gene expression measurements from fine needle aspirates of pancreatic tumors: effect of amplicon length and quality assessment.Current status of molecular markers for early detection of sporadic pancreatic cancer.A novel five-antibody immunohistochemical test for subclassification of lung carcinoma.TRIM29 suppresses TWIST1 and invasive breast cancer behavior.Molecular Imaging with MRI: Potential Application in Pancreatic Cancer.MicroRNA profiling of diagnostic needle aspirates from patients with pancreatic cancer.Differential gene expression analysis of peripheral blood mononuclear cells reveals novel test for early detection of pancreatic cancer.Theranostic nanoparticles with controlled release of gemcitabine for targeted therapy and MRI of pancreatic cancer.uPAR-targeted optical imaging contrasts as theranostic agents for tumor margin detection.Acetylation of FOXM1 is essential for its transactivation and tumor growth stimulation.Novel quantitative analysis of the S100P protein combined with endoscopic ultrasound-guided fine needle aspiration cytology in the diagnosis of pancreatic adenocarcinoma.Involvement of urokinase-type plasminogen activator system in cancer: an overview.Diagnostic value of S100P for pancreatic cancer: a meta-analysis.A Comparative Study of Clinical Intervention and Interventional Photothermal Therapy for Pancreatic Cancer.Current status of biomarker and targeted nanoparticle development: The precision oncology approach for pancreatic cancer therapy.Prognostic Impact of Urokinase Plasminogen Activator Receptor Expression in Pancreatic Cancer: Malignant Versus Stromal Cells.beta(2)microglobulin mRNA expression levels are prognostic for lymph node metastasis in colorectal cancer patients.MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease.MicroRNAs in pancreatic ductal adenocarcinoma.Plectin-1 Targeted Dual-modality Nanoparticles for Pancreatic Cancer Imaging.Targeting Epigenetic Aberrations in Pancreatic Cancer, a New Path to Improve Patient Outcomes?Enhanced expression of proproliferative and antiapoptotic genes in ulcerative colitis-associated neoplasia.Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications.
P2860
Q24642374-6D38C1D5-F6A3-4F30-A8BA-126150A6346FQ24652981-2E92F121-4B12-458F-A5F6-209349239632Q27011806-1438B3A0-C8F7-4709-8C61-D1B681CC112FQ30539738-F1CFB788-E88C-4903-AEE0-22334A0D9E15Q33403662-C3E174D8-4426-4333-A7D2-99157DF5FB6FQ33693132-CF545386-7F33-413C-AB74-29DD2D55DBA1Q33694015-633169C2-E7C8-43B0-9970-F058935B2080Q33703133-8335CF9A-39F8-44A6-B695-2C8819319E2BQ34009539-DA0083F1-AE3C-4934-9594-A3099048850AQ34067856-67D787D3-2342-471B-95B9-C9FFADFF07CAQ34084824-833BC35E-EE4E-4CF8-9F9F-9F3A65AB137CQ34458903-8D350977-FB7F-45A3-BE98-2573874BABA3Q34980292-CAAFAEEC-4504-4FC0-819B-326A0F980B92Q35087555-A556F794-393A-4727-9660-8E500DB455B5Q36249508-6379AB1E-428F-4BB9-8605-DF8A017056EDQ36387904-ACAEDCF9-A408-4D35-BEE9-CF73D7186AF4Q36570435-A0787773-00C2-4CB6-A3A9-8741DD0AFDACQ36721737-A93BFB74-72EB-4CF9-A623-2FA7A2A37FAEQ37435242-5FA93380-2C0A-415D-85D2-5B5FAB86A17DQ37645028-0F16E4CE-9B41-4298-8ABE-F7F5A64A23FBQ37722098-1016CBA0-80F8-4B09-B3FD-71273E75C6DEQ38189275-24923440-6E77-4F1D-BC53-053956F8A053Q38239858-0BCD2845-7F81-4297-9A9A-BA43A2B71073Q38662058-CC89F956-4155-404C-AE84-014728AF2099Q39028976-5B1BC8D8-5AF6-4B7B-B58E-936B77A2ED32Q39424309-2122EDA9-B08D-4ACB-917F-B887C4BEB8E1Q39637991-124365EB-2ED0-44D2-AC11-2DA5C1C001F1Q39950193-FC56FC1E-419B-45E7-9A13-335321218653Q42662249-384C9ACF-4A67-4EF2-8C13-74A6B6625FC0Q51735492-31742B57-348D-4CB9-B8F9-A1FD7F2FB463Q52715499-B3B945C4-EF75-4BCA-9FF0-1E5BE1DFE067Q53303481-55248298-FBBC-4EC1-B329-6DAFD49570F0Q54960825-B8DA535D-5F5E-4B78-BCBA-E38F005B7EF0
P2860
Accurate discrimination of pancreatic ductal adenocarcinoma and chronic pancreatitis using multimarker expression data and samples obtained by minimally invasive fine needle aspiration.
description
2007 nî lūn-bûn
@nan
2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Accurate discrimination of pan ...... vasive fine needle aspiration.
@ast
Accurate discrimination of pan ...... vasive fine needle aspiration.
@en
type
label
Accurate discrimination of pan ...... vasive fine needle aspiration.
@ast
Accurate discrimination of pan ...... vasive fine needle aspiration.
@en
prefLabel
Accurate discrimination of pan ...... vasive fine needle aspiration.
@ast
Accurate discrimination of pan ...... vasive fine needle aspiration.
@en
P2093
P2860
P356
P1476
Accurate discrimination of pan ...... vasive fine needle aspiration.
@en
P2093
Amanda Graham
Brenda J Hoffman
David H Robbins
David J Cole
David N Lewin
Kaidi Mikhitarian
Laurrie Rumpp
Michael Mitas
Tammy Glenn
P2860
P304
P356
10.1002/IJC.22487
P577
2007-04-01T00:00:00Z